Production
Plant
Our production state-of-art plant is one of the largest in Spain with more than 35,000 m2 of facilities equipped with the sector’s most advanced technology and a high capacity, meeting the highest quality standards. It will become the Excellence Centre for controlled-release products of Towa Pharmaceutical (Japan).

Our production plant is one of the largest in Spain in advanced technology of modified release
0
Employees
~4,2B
Doses per year
0
Million packs / year (capacity)
Our new High-Containment facility
The new High-Containment area at our production plant in Martorelles, Barcelona, expands our capabilities in the manufacturing of highly potent oral solid medicines. A purpose-built production environment combining advanced containment, integrated manufacturing capabilities and dedicated R&D for highly potent medicines.
Advanced containment technologies are integrated throughout the manufacturing process:
- Controlled manufacturing environment
- Secure API transfer through split-valve systems
- Integrated WIP/CIP systems
- Minimized operator exposure
- Protection of product integrity
Designed for
regulatory readiness
The facility has been designed and constructed to meet FDA requirements and international regulatory expectations, with a design that supports readiness for health authority inspections across global markets.
Dedicated R&D
capabilities
The facility also includes a dedicated R&D area for highly potent pharmaceutical products, supporting formulation development, process optimisation and scale-up towards industrial manufacturing.
Integrated
manufacturing
From powder to finished dosage form, the facility integrates the key stages of oral solid dose manufacturing. Prepared to work with proprietary products and act as a CMO or CdMO.







